EUVIMEDEUVIMED entdecken
Crossref

Spectrum of Germline Cytogenomic Alterations in RB1 in Mexican Patients With Retinoblastoma

Jose de Jesus Perez-Becerra iD, Sinhue Alejandro Brukman-Jimenez, Juan Antonio Ramirez-Corona, Alfredo Corona-Rivera, Jorge Román Corona-Rivera, Katia Alejandra Castillo-Reyes, Graciela Gonzalez-Perez, Aurea Márquez-Mora, Graciela Serafin-Saucedo, Violeta Cassandra Vera-Cuevas, Uriel Francisco Santana-Bejarano, Mireya Orozco-Vela und 1 weitere

Pediatric Blood & Cancer · 2026-06 · 73 (6)

DOI: 10.1002/1545-5017.70267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 27.03.2026. Verfasst von Jose de Jesus Perez-Becerra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Human Genetics PhD Program, Department of Molecular Biology and Genomics, Centro Universitario de Ciencias de La Salud, Universidad De Guadalajara, G…. Hauptthemen laut MEDLINE: Retinoblastoma, Ubiquitin-Protein Ligases, Retinoblastoma Binding Proteins, Germ-Line Mutation. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study was to characterize the spectrum of germline cytogenomic alterations in RB1 in Mexican patients with retinoblastoma. Procedures Genomic DNA was isolated from peripheral blood from 88 Mexican patients with retinoblastoma RB (56 unilateral and 32 bilateral) treated at the Civil Hospital of Guadalajara between 2014 and 2024. Single nucleotide variants (SNVs) were analyzed by next generation sequencing (NGS) using a custom RB1 panel. Large RB1 deletions were assessed by multiplex ligation‐dependent probe amplification (MLPA), whereas fluorescence in situ hybridization (FISH) and G‐banding karyotyping were applied following a hierarchical workflow based on institutional resources to identify deletions at 13q14.

Results

Germline cytogenomic alterations were identified in 37 of the 88 patients (42.1%). Among these, 30 had bilateral RB and 7 had unilateral RB. Detection rates were 93.7% (30/32) in bilateral cases and 12.5% (7/56) in unilateral cases. Of the total cytogenomic alterations, 72.9% (27/37) were SNVs and 27.1% (10/37) were large deletions.

Conclusions

This study provides an overview of the spectrum of germline cytogenetic alterations and clinical features in Mexican patients with RB. Our results expand the understanding of RB in this population and underscore the need for multimodal approaches for the detection and functional characterization of RB1 alterations. This study reports the largest Mexican retinoblastoma cohort with comprehensive germline RB1 characterization and high detection rates, particularly in bilateral disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaUbiquitin-Protein LigasesRetinoblastoma Binding ProteinsGerm-Line MutationPolymorphism, Single NucleotideRetinal NeoplasmsHumansFemaleMaleChild, PreschoolMexicoInfantChildPrognosisHigh-Throughput Nucleotide SequencingIn Situ Hybridization, FluorescenceFollow-Up Studies

Stichwörter der Autor:innen

KaryotypeRB1 genefluorescent in situ hybridization (FISH)multiplex ligation‐dependent probe amplification (MLPA)next generation sequencing (NGS)retinoblastoma

Substanzen

Ubiquitin-Protein LigasesRB1 protein, humanRetinoblastoma Binding Proteins

Autor:innen und Institutionen

  • Human Genetics PhD Program, Department of Molecular Biology and Genomics, Centro Universitario de Ciencias de La Salud, Universidad De Guadalajara, Guadalajara, Mexico.
  • Human Genetics Institute "Dr. Enrique Corona Rivera", Department of Molecular Biology and Genomics, Centro Universitario de Ciencias de La Salud, Universidad De Guadalajara, Guadalajara, Mexico.
  • Cytogenetics Unit, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Mexico.
  • Center for Registry and Research in Congenital Anomalies (CRIAC), Service of Genetics and Cytogenetics Unit, Pediatrics Division, Dr. Juan I. Menchaca Civil Hospital of Guadalajara, Guadalajara, Jalisco, Mexico.
  • Ophthalmology Department, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico.
  • Innovation and Development, Abalat, Ciudad de México, Mexico.

ORCID-Profile: Jose de Jesus Perez-Becerra

Förderung

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI)

Zitieren

APA

Perez-Becerra, J. J., Brukman-Jimenez, S. A., Ramirez-Corona, J. A., Corona-Rivera, A., Corona-Rivera, J. R., Castillo-Reyes, K. A., Gonzalez-Perez, G., Márquez-Mora, A., Serafin-Saucedo, G., Vera-Cuevas, V. C., Santana-Bejarano, U. F., Orozco-Vela, M., & Bobadilla-Morales, L. (2026). Spectrum of Germline Cytogenomic Alterations in RB1 in Mexican Patients With Retinoblastoma. Pediatric Blood & Cancer, 73(6). https://doi.org/10.1002/1545-5017.70267

Vancouver

Perez-Becerra JJ, Brukman-Jimenez SA, Ramirez-Corona JA, Corona-Rivera A, Corona-Rivera JR, Castillo-Reyes KA, et al. Spectrum of Germline Cytogenomic Alterations in RB1 in Mexican Patients With Retinoblastoma. Pediatric Blood & Cancer. 2026;73(6). doi:10.1002/1545-5017.70267

BibTeX
@article{PerezBecerra2026,
  author = {Perez-Becerra, Jose de Jesus and Brukman-Jimenez, Sinhue Alejandro and Ramirez-Corona, Juan Antonio and Corona-Rivera, Alfredo and Corona-Rivera, Jorge Román and Castillo-Reyes, Katia Alejandra and Gonzalez-Perez, Graciela and Márquez-Mora, Aurea and Serafin-Saucedo, Graciela and Vera-Cuevas, Violeta Cassandra and Santana-Bejarano, Uriel Francisco and Orozco-Vela, Mireya and Bobadilla-Morales, Lucina},
  title = {Spectrum of Germline Cytogenomic Alterations in RB1 in Mexican Patients With Retinoblastoma},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  volume = {73},
  number = {6},
  doi = {10.1002/1545-5017.70267}
}
Kostenlos starten →